Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
20.8 AUD | -9.97% | +0.43% | -16.70% |
28/05 | Transcript : Neuren Pharmaceuticals Limited - Shareholder/Analyst Call | |
27/05 | Neuren Phase 2 Trial Shows Significant Improvements in Pitt Hopkins Syndrome | CI |